Where Tech Meets Bio
Subscribe
Sign in
Home
Podcast
Archive
About
Latest
Top
Discussions
Weekly Tech+Bio Highlights #19
ALSO: Generative AI vs. Fatal Lung Disease; This Company Claims New “Gold Standard“ for Microscopy Data Analysis; Rethinking Gene Delivery with ML, and…
Nov 19
•
BiopharmaTrend
,
Roman Kasianov
, and
Andrii Buvailo
4
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #19
Copy link
Facebook
Email
Notes
More
A New Kid On the Block: AI World Models In Biotech
LLMs are all the rage now, but they (likely) won't get us to real drug discovery revolution. So.. what's next?
Nov 14
•
Andrii Buvailo
and
BiopharmaTrend
3
Share this post
Where Tech Meets Bio
A New Kid On the Block: AI World Models In Biotech
Copy link
Facebook
Email
Notes
More
2
Demis Hassabis on What's Next for AI in Biotech
ALSO: Adapting to Change in Clinical Development; AI is Key to Democratizing Drug Discovery; 10 Companies to Watch in Precision Medicine...
Nov 11
•
Andrii Buvailo
,
BiopharmaTrend
, and
Roman Kasianov
3
Share this post
Where Tech Meets Bio
Demis Hassabis on What's Next for AI in Biotech
Copy link
Facebook
Email
Notes
More
On Predicting Probability of Technical and Regulatory Success With AI
Insights from The American Society of Clinical Oncology (ASCO) Annual Meeting 2024
Nov 7
•
BiopharmaTrend
8
Share this post
Where Tech Meets Bio
On Predicting Probability of Technical and Regulatory Success With AI
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #18
ALSO: Kidney-On-Chip in Space; New Foundation Model for Small Molecule Discovery; Adaptive Oncology Trials...
Nov 4
•
Roman Kasianov
and
BiopharmaTrend
2
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #18
Copy link
Facebook
Email
Notes
More
October 2024
Key Trends in Aging Research: Where Are We Now?
And my thoughts on what is available to an "average person," like myself, in terms of being able to live healthier and longer.
Oct 31
•
Andrii Buvailo
5
Share this post
Where Tech Meets Bio
Key Trends in Aging Research: Where Are We Now?
Copy link
Facebook
Email
Notes
More
8 AI Companies to Watch in Clinical Trials
ALSO: A Map of Antibiotic Resistance; Deep Mind Introduces Tx-LLM; Antibody Discovery Beyond AlphaFold; LLC Business Model in Biotech
Oct 21
•
Andrii Buvailo
,
Roman Kasianov
, and
BiopharmaTrend
8
Share this post
Where Tech Meets Bio
8 AI Companies to Watch in Clinical Trials
Copy link
Facebook
Email
Notes
More
2
Eli Lilly, Pfizer, Moderna... Pharma is Embracing AI Trend
ALSO: A New AI Chatbot for Biotech Investors; This Company Is Building AI Infrastructure for Life Sciences
Oct 14
•
Andrii Buvailo
4
Share this post
Where Tech Meets Bio
Eli Lilly, Pfizer, Moderna... Pharma is Embracing AI Trend
Copy link
Facebook
Email
Notes
More
Nobel Prize Awarded for AI-Driven Protein Research!
Who are the winners and what do they do? ALSO: 13 Companies To Watch in the AI-driven Protein Design Space
Oct 9
•
Andrii Buvailo
4
Share this post
Where Tech Meets Bio
Nobel Prize Awarded for AI-Driven Protein Research!
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #17
ALSO: Flagship Pioneering's New AI Platform; AI-Optimized 3D Printing for Organ Models; How VCs and Pharma Form Novel Business Models; Cell Therapy…
Oct 1
8
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #17
Copy link
Facebook
Email
Notes
More
September 2024
Weekly Tech+Bio Highlights #16
Brain Chip Scores FDA’s ‘Breakthrough Device’; Positive Phase IIa Results for AI-Designed Drug; New Letters in Genetic Alphabet; News in Gen AI for…
Sep 24
6
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #16
Copy link
Facebook
Email
Notes
More
Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience
How one Texas-based company is creating a universal antimicrobial drug, and trying to tackle aging along the way
Sep 20
•
Andrii Buvailo
5
Share this post
Where Tech Meets Bio
Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts